Brief: Bristol Myers To Buy Karuna Therapeutics For $14 Bln - WSJ
Dec 22 (Reuters) -
* BRISTOL MYERS TO BUY KARUNA THERAPEUTICS FOR $14 BILLION -
WSJ
* BRISTOL WOULD PAY $330 A SHARE IN CASH FOR KARUNA AND ITS
EXPERIMENTAL SCHIZOPHRENIA DRUG NOW UP FOR U.S. GOVERNMENT
APPROVAL - WSJ
Source text:http://tinyurl.com/ysuzve53
Further company coverage: BMY.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Karuna Therapeutics
See all newsMoody's says pharma outlook turns 'positive' on GLP-1 drug push
Brief: Karuna Therapeutics Says Complaint Was Filed By Karuna Stockholder Seeking To Enjoin Proposed Merger With Bristol-Myers Squibb
Karuna Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Karuna Therapeutics Inc expected to post a loss of $2.65 a share - Earnings Preview
Bristol Myers posts better-than-expected 4th-quarter results (updated)